Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the SURPASS trials (focused on type 2 diabetes), 15 mg of tirzepatide reduced HbA1c by up to 2.58 percentage points, bringing many participants to normal glycemic levels
The medication is administered as a once-weekly subcutaneous injection , with doses gradually increased over 16-20 weeks to minimise gastrointestinal side effects
Myelopathy Neurological impairment caused by compression of the spinal cord
Review these criteria with your doctor before enquiring Diagnosed with type 2 diabetes needing improved glycemic control alongside diet and exercise Adult with obesity, or overweight with a weight-related condition, prescribed for chronic weight management Comfortable with a once-weekly self-injection routine Seeking a WHO-GMP certified generic Semaglutide by Incepta Pharmaceuticals Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome History of pancreatitis Type 1 diabetes or diabetic ketoacidosis Pregnant, planning pregnancy within 2 months, or breastfeeding Check Availability & Pricing Prescription required Named Patient Program Worldwide shipping WHO-GMP Certified Prescription verified Express dispatch What is Fitaro
